Literature DB >> 12858206

Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission.

G Dini1, M Grazia Valsecchi, C Micalizzi, A Busca, A Balduzzi, W Arcese, S Cesaro, A Prete, M Rabusin, E Mazzolari, P Di Bartolomeo, N Sacchi, A Pession, G Giorgiani, E Lanino, T Lamparelli, C Favre, A Bosi, C Manzitti, S Galimberti, F Locatelli.   

Abstract

We analyzed the outcome of 167 consecutive children with second CR acute lymphoblastic leukemia (ALL), for whom an unrelated donor (UD) search was activated between 1989 and 1998 at a median time of 2 months after relapse. A suitable donor was identified for 70 patients at 1 year and 6.5 months before and after 1995 from search activation, respectively; a further leukemia relapse occurred during the search in 94 children at a median of 4 months after search activation, 36 of whom underwent UD (14) or other types of transplant (22), beyond second CR, while 58 died of progressive disease. Of 73 patients not experiencing a second relapse, 64 underwent UD (46) or other types of transplant (18), while nine proceeded with chemotherapy, and only four of them survived. The 3-year disease-free survival (DFS) from second CR for the 167 patients is 15.1%, whereas 3-year DFS after transplant for the 60 UD and 40 alternative donor transplanted children is 31.6 and 25.4%, respectively. In conclusion, a further relapse is the main factor adversely affecting outcome of children with second CR ALL. Thus, for these patients, the search should be activated early after relapse and either a UD or an alternative transplant should be performed as early as possible.

Entities:  

Mesh:

Year:  2003        PMID: 12858206     DOI: 10.1038/sj.bmt.1704132

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

Review 1.  Interpreting outcome data in hematopoietic cell transplantation for leukemia: tackling common biases.

Authors:  Y Ofran; H M Lazarus; A P Rapoport; J M Rowe
Journal:  Bone Marrow Transplant       Date:  2015-01-12       Impact factor: 5.483

Review 2.  Hematopoietic stem cell transplantation for leukemia.

Authors:  Alan S Wayne; Kristin Baird; R Maarten Egeler
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

3.  Outcomes of strategic alternative donor selection or suspending donor search based on Japan Marrow Donor Program coordination status.

Authors:  Naomi Kawashima; Satoshi Nishiwaki; Naoko Shimizu; Sonoko Kamoshita; Kyoko Watakabe; Emi Yokohata; Shingo Kurahashi; Yukiyasu Ozawa; Koichi Miyamura
Journal:  Int J Hematol       Date:  2018-01-27       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.